Epic Research Update : Jubilant Life Sciences

Jubilant Life Sciences, an integrated Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Mycophenolate Mofetil USP, 250 mg Capsules and 500 mg Tablets from its US subsidiary, Jubilant Cadista Pharmaceuticals Inc. and Rizatriptan Tablets 5 mg and 10 mg from its Indian subsidiary, Jubilant Generics.



Real Time News & Trading Trends Keep Liking #EpicResearch



Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+



For more information ✆ – 0731-6642300 or Visithttp://ift.tt/1k8NnLH

Posted in: Indian Market Tips